Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History CLDX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics CLDX

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Celldex Therapeutics Inc

CLDX
Current price
22.41 USD -0.75 USD (-3.24%)
Last closed 22.97 USD
ISIN US15117B2025
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 1 487 894 016 USD
Yield for 12 month -38.33 %
1Y
3Y
5Y
10Y
15Y
CLDX
21.11.2021 - 28.11.2021

Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic antibodies for patients with severe inflammatory, allergic, autoimmune, and other diseases. The company's drug candidates include monoclonal and bispecific antibodies designed to address mast cell mediated diseases for which available treatments are inadequate. Its clinical development programs are Barzolvolimab (CDX-0159), a monoclonal antibody that specifically binds the KIT receptor and potently inhibits its activity for treating chronic urticarias, prurigo nodularis, eosinophilic esophagitis, and atopic dermatitis; and CDX-622, a bispecific candidate for inflammatory diseases, which targets two complementary pathways that drive chronic inflammation, potently neutralizing the alarmin thymic stromal lymphopoietin and depleting mast cells through stem cell factor starvation. The company is headquartered in Hampton, New Jersey. Address: Perryville III Building, Hampton, NJ, United States, 08827

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

58.54 USD

P/E Ratio

Dividend Yield

Financials CLDX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures CLDX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+7 020 000 USD

Last Year

+6 883 000 USD

Current Quarter

+695 000 USD

Last Quarter

+1 175 000 USD

Current Year

+7 020 000 USD

Last Year

+3 875 000 USD

Current Quarter

+695 000 USD

Last Quarter

+356 000 USD
EBITDA -213 940 000 USD
Operating Margin TTM -9 027.19 %
Price to Earnings
Return On Assets TTM -16.88 %
PEG Ratio
Return On Equity TTM -23.20 %
Wall Street Target Price 58.54 USD
Revenue TTM 7 559 000 USD
Book Value 10.59 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 345.50 %
Dividend Yield
Gross Profit TTM -176 944 000 USD
Earnings per share -2.70 USD
Diluted Eps TTM -2.70 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation CLDX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 112.08
Price Sales TTM 196.84
Enterprise Value EBITDA -17.34
Price Book MRQ 2.16

Technical Indicators CLDX

For 52 Weeks

14.40 USD 47.00 USD
50 Day MA 20.75 USD
Shares Short Prior Month 7 828 519
200 Day MA 23.05 USD
Short Ratio 6.93
Shares Short 7 873 818
Short Percent 13.93 %